Journal Article
L. E. Bermudez, Wu, M., and Young, L. S.,
“Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.”,
The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S.,
“Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”,
Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. S. Young, Gascon, R., Alam, S., and Bermudez, L. E.,
“Monoclonal antibodies for treatment of gram-negative infections.”,
Reviews of infectious diseases, vol. 11 Suppl 7, pp. S1564-71, 1989.
L. S. Young, Bermudez, L. E., and Inderlied, C. B.,
“Mycobacteria and AIDS: treatment, prevention and future prospects.”,
Research in microbiology, vol. 143, no. 4, pp. 420-2, 1992.
L. E. Bermudez, Inderlied, C. B., and Young, L. S.,
“Mycobacterium avium complex in AIDS.”,
Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.
N. Azouaou, Petrofsky, M., Young, L. S., and Bermudez, L. E.,
“Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.”,
Immunology, vol. 91, no. 3, pp. 414-20, 1997.
N. Mohagheghpour, Gammon, D., van Vollenhoven, A., Hornig, Y., Bermudez, L. E., and Young, L. S.,
“Mycobacterium avium reduces expression of costimulatory/adhesion molecules by human monocytes.”,
Cellular immunology, vol. 176, no. 1, pp. 82-91, 1997.
L. E. Bermudez, Kolonoski, P., and Young, L. S.,
“Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model.”,
Journal of leukocyte biology, vol. 47, no. 2, pp. 135-41, 1990.
L. E. Bermudez, Wu, M., Enkel, H., and Young, L. S.,
“Naturally occurring antibodies against Mycobacterium avium complex.”,
Annals of clinical and laboratory science, vol. 19, no. 6, pp. 435-43, 1989.
L. S. Young and Bermudez, L. E.,
“Perspective on animal models: chronic intracellular infections.”,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 33 Suppl 3, pp. S221-6, 2001.
L. E. Bermudez and Young, L. S.,
“Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages.”,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 20, no. 2, pp. 191-201, 1987.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B.,
“Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”,
The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.
L. S. Young, Bermudez, L. E., and Inderlied, C. B.,
“Practical issues in the antibiotic and immunotherapy of Mycobacterium avium disease in immunocompromised patients.”,
Research in microbiology, vol. 145, no. 3, pp. 206-9, 1994.
J. Champsi, Young, L. S., and Bermudez, L. E.,
“Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.”,
Immunology, vol. 84, no. 4, pp. 549-54, 1995.
L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S.,
“Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”,
Cytokine, vol. 2, no. 4, pp. 287-93, 1990.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”,
The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.
N. Hsu, Young, L. S., and Bermudez, L. E.,
“Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex.”,
Infection and immunity, vol. 63, no. 2, pp. 528-33, 1995.
L. E. Bermudez, Young, L. S., and Inderlied, C. B.,
“Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.
J. H. Champsi, Bermudez, L. E., and Young, L. S.,
“The role of cytokines in mycobacterial infection.”,
Biotherapy (Dordrecht, Netherlands), vol. 7, no. 3-4, pp. 187-93, 1994.
L. E. Bermudez, Kolonoski, P., and Young, L. S.,
“Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.
L. E. Bermudez, Inderlied, C., and Young, L. S.,
“Stimulation with cytokines enhances penetration of azithromycin into human macrophages.”,
Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.